Would induction of dopamine homeostasis via coupling genetic addiction risk score (GARS®) and pro-dopamine regulation benefit benzodiazepine use disorder (BUD)?

Prescriptions for Benzodiazepines (BZDs) have risen continually. According to national statistics, the combination of BZDs with opioids has increased since 1999. BZDs (sometimes called “benzos”) work to calm or sedate a person by raising the level of the inhibitory neurotransmitter GABA in the brain...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:J Syst Integr Neurosci
Autores principales: Blum, K, Gold, M, Modestino, EJ, Baron, D, Boyett, B, Siwicki, D, Lott, L, Podesta, A, Roy, AK, Hauser, M, Downs, BW, Badgaiyan, RD
Formato: Artigo
Lenguaje:Inglês
Publicado: 2018
Materias:
Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC6865059/
https://ncbi.nlm.nih.gov/pubmed/31750006
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.15761/JSIN.1000196
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares